Minapharm’s manufacturing facility supports the production of more than 150 pharmaceutical and biopharmaceutical products.
The automated plant manufactures products ranging from small-molecule medicines to complex bioengineered therapies.
Its operations follow cGMP, ISO and World Health Organization pharmaceutical manufacturing standards.
The wider development also supports advanced therapeutic-protein and vaccine production using specialised engineering and electromechanical systems.